You are here


2022 Technology Showcase

Primary tabs

2022 Technology Showcase, National Cancer Institute and the Frederick National Laboratory

Thank you for helping to make the 6th annual Technology Showcase another great event!

View the recording

A Hybrid event on September 7, 2022


Frederick National Laboratory

Advanced Technology Research Facility (ATRF)
8560 Progress Drive, Frederick, MD 21701

TIME: 12:00 - 5:30 pm ET (times approximate)


Frederick National Laboratory, Advanced Technology Research Facility

Event Overview:

  • Free, half-day in-person and online event.
  • Features NCI and FNL program and research leaders who will highlight licensing and partnering opportunities.
  • Learn about technologies primed for commercialization and/or collaboration; great opportunity for biotech stakeholders and companies of all sizes including start-ups.
  • Showcases how to partner with the NCI and the FNL including the company perspective.
  • Attend panel sessions focused on technology commercialization.
  • Lightning Pitch followed by Poster Session highlighting additional NIH technologies available for licensing and collaborative development - presented by the NCI Technology Transfer Ambassadors Program.
  • In-person networking and online engagement opportunities. 
  • The Technology Showcase will conclude with an independently sponsored networking event nearby without involving any resources of the Department of Health and Human Services.


11:15 am - In-person check-in

11:30 am - Join online

12:00 pm - Welcome

Ethan Dmitrovsky, M.D., Director, Frederick National Laboratory
Michael Salgaller, Ph.D., Unit Supervisor, NCI Technology Transfer Center, Technology Analysis and Marketing Unit 

12:05 - 12:20 pm - Keynote presentation

Keynote Presenter:

NCI Acting Director, Dr. Douglas R. Lowy


12:20 - 12:25 pm - The Voice of the Patient

Sue Scott, cancer survivor, patient advocate and NCI clinical trial participant

12:25 - 1:25 pm - Technology Session 1

(presenter order subject to change)
Moderator: Michael Salgaller, NCI TTC 

Session introduction and instructions: Michele Newton, NCI TTC, Communications Specialist, Event Co-Chair

1:30 - 2:20 pm - Panel Sessions, Set 1

(attendees select 1)

  1. “How Collaborators Can Tap into Laboratory Resources at the Frederick National Laboratory”
    Moderator: Vladimir Popov, Ph.D.,
    Director, Partnership Development Office, FNL
    Panelists: Dwight V. Nissley, Ph.D., Director, Cancer Research Technology Program FNL
    Uma Mudunuri, M.S., Director, Advanced Biomedical Computational Science (ABCS), FNL
    Claire Deleage, Ph.D., Scientist, AIDS and Cancer Virus Program, FNL
  2. “Government and Venture Funding”
    Moderator: Jodie Bollinger
    , Acting Executive Director, Frederick County Office of Economic Development
    Panelists: William Bozza, Ph.D., Program Director, NCI SBIR
    Christine Copple, Ph.D., President and CEO, ASM Resources 
    Ulyana Desiderio, Ph.D., Director of BioHealth and Life Sciences, MD Department of Commerce

    Katherine Hill Ritchie, M.B.A., Senior Director, Venture Funds, TEDCO

2:20 - 2:35 pm Lightning Pitch presented by NCI Technology Transfer Ambassadors Program (TTAP)

Presenters will each deliver a one-minute "lightning pitch." Attendees can then opt to learn more by stopping by the posters displayed in-person.
The pitch and poster for posters 9-10 will be presented virtually; online attendees will have an opportunity to learn more about all of the posters.

Moderator: Laura Prestia, Ph.D., NCI TTC, Communications and Strategic Initiatitves Manager, TTAP Lead

1. Presented by: Sarwat Naz, Ph.D., Technology Transfer Fellow, NCI TTC
Inventor: Yves Pommier, M.D., Ph.D.,
Chief, Developmental Therapeutics Branch, NCI CCR
"Use of Acetalax for Treatment of Triple Negative Breast Cancer" (E-041-2018) 
2. Presented by: Gabrielle O'Brien, TTAP Ambassador
Inventor: Steven Rosenberg, M.D., Chief, NCI CCR Surgery Branch
"T-cell Receptors Targeting Human Papillomavirus Oncoproteins" (E-176-2014)
3. Presented by: Andrew Sinkoe, Ph.D., Transition to Industry (T2I) Fellow and Co-Inventor
Inventors: James Gulley, M.D., Ph.D.,
Co-Director, Center for Immuno-Oncology; Andrew Sinkoe
"Liquid Biopsy Biomarker to Predict Immunotherapy Efficacy" (E-045-2022)
4. Presented by: Bau-Lin Huang, Ph.D., TTAP Ambassador
Inventor: Matthew T. Wolf, Ph.D,
Stadtman Investigator, Cancer Innovation Laboratory, NCI CCR
"Method for Assembling Decellularized Tissue Extracellular Matrix in 3D Tumor Spheroids" (E-127-2022)
5. Presented by: Larisa Gearhart-Serna, Ph.D., M.B.A., Technology Transfer Innovation Fellow, NCI TTC
Inventor: James Doroshow, M.D.,
Deputy Director for Clinical and Translation Rearch, Developmental Therapeutics Branch, NCI
"Iodonium Analogs as Inhibitors of NADPH Oxidases and Other Flavin Dehydrogenases and Their Use for Treating Cancer" (E-116-2014)
6. Presented by: Renata Marchette, Ph.D., TTAP Ambassador
Inventor: Amy Hauck Newman, Ph.D., Scientific Director, Molecular Targets and Medications Discovery Branch, Medicinal Chemistry Section, NIDA
"D3 Receptor Agonist Compounds; Methods of Preparation; Intermediates Thereof; and Methods of Use Thereof" (E-077-2019)
7Presented by: Nick Bernier, Ph.D., Technology Transfer Fellow, NCI TTC
Inventor: Peng Loh, Ph.D., Senior Investigator, Section on Cellular Neurobiology, NICHD
"Use of Neurotrophic Factor-alpha1/Carboxypeptidase E (CPE) to Treat Alzheimer Disease" (E-200-2021)
8. Presented by: Lidia Beka, Ph.D., Technology Transfer Fellow, NCI TTC
Inventor: Robert Hufnagel, M.D., Ph.D.,
Lasker Clinical Research Scholar, NEI 
"Sensitive and Economic RNA Virus Detection Using a Novel RNA Preparation Method​" (E-195-2020)
*9. Presented by: Susheel Kumar, Ph.D., TTAP Ambassador
Inventor: Sankar Adhya, Ph.D., Senior Investigator, Laboratory of Molecular Biology, NCI CCR
"Bacteriophage Lambda Vaccine System" (E-113-2021) 
*10. Presented by: Ali Mehdi, MBA; Swikriti Dasgupta, **Business Students, Johns Hopkins University
Inventor: Genoveffa Franchini, M.D., Senior Investigator, Vaccine Branch, NCI CCR
"Immunogens for Use in a High Efficacy HIV Vaccine" (E-160-2018)

*Virtual pitch and poster presenters;
** poster developed through the TTAP partnership with the Johns Hopkins University (Carey Business School) "Discovery to Market" course.

2:35 - 3:25 pm - Networking and Poster Session

3:25 - 4:25 pm - Technology Session 2 

(presenter order subject to change)
Moderator: Paul Zelenski, M.S., M.B.A., Executive Director, Federal Laboratory Consortium

Session introduction and instructions: Michele Newton, NCI TTC

4:30 - 5:20 pm - Panel Sessions, Set 2

(attendees select 1)

3. “Non-traditional and Foundation Sources of Support”

Moderator:  Stephen Auvil, M.S., M.B.A., Chief Program Operations Officer, TEDCO
Panelists: Sujuan Ba, Ph.D., President and CEO, National Foundation for Cancer Research
Ernesto Chanona, Ph.D., Director of Business Development and Government Affairs, CSSi Life Sciences
Bret Schreiber, Vice President, Life Sciences and Technology at the Fulton Financial Corporation

4. “How to Work with the NCI”
Moderator: Christie Canaria, Ph.D.
, Interagency Policy Specialist, NIST
Panelists: David Oarr, President, Cytimmune Sciences
Steven Pavletic, M.D., M.S., Senior Clinician Immune Deficiency Cellular Therapy Program, NCI CCR
Richard Rodriguez, M.B.A., Associate Director, NCI Technology Transfer Center
Jeffrey Strovel, Ph.D., CEO, Veralox Therapeutics, Inc.

5:20 - Closing remarks, Thank you!

Networking Event

An independently sponsored networking event will take place nearby without involving any resources of the Department of Health and Human Services


Friday, February 17, 2023